Science has undergone significant progress and change over the past century and even in the last few decades. In some cases, novel and emerging fields have developed at a faster rate than parliamentary governance and ethical regulations can follow which has left many fields with little local and international regulation and dangerous potential.
What ethical aspects do scientists working in these fields have to consider? How can governance infrastructures be developed that do not hinder scientific progress all while maintaining ethical and safe boundaries? This panel discussion will seek to answer these questions and more in the frame of three contemporary and emerging fields: AI, gene editing, and medical trials.